Video
Benefits of TTR Gene Silencers
Author(s):
Discussion on the role of TTR protein stabilizers and gene silencers for treating hereditary ATTR amyloidosis.
John L. Berk, MD: Dr Polydefkis, Dr Witteles suggested that the earlier the better with most effective therapy, alluding to TTR gene silencers. Let’s say I have fairly advanced, previously undiagnosed TTR amyloid neuropathy. I’m seeking your advice; am I out of luck in terms of getting benefits from the TTR gene silencers?
Michael J. Polydefkis, MD: No. It’s been shown that irrespective of neuropathy severity, you’ll still experience a benefit from silencer therapy. This means that your disease will be likely halted. You may not improve dramatically, you may not go from a cane to running marathons, but you won’t regress to 2 canes or to a wheelchair.
John L. Berk, MD: Thank you for watching this NeurologyLive® Peer Exchange. If you enjoyed the content, please subscribe to our e-newsletters to receive upcoming Peer Exchanges and other great content right in your inbox.
Transcript Edited for Clarity
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
